Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication - US Preventive Services Task Force

Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication - US Preventive Services Task Force

Final Research Plan: Aspirin Use to Prevent Preeclampsia

Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality The U.S. Preventive Services Task Force posted today a final research plan on aspirin use to prevent preeclampsia and related morbidity and mortality. The draft research plan for this topic was posted for public comment from June 20, 2019 to July 17, 2019. The Task Force reviewed all of the comments that were submitted and took them into consideration as it finalized the research plan. To view the final research plan, please go here. The Final Research Plan Is Available

FROM DRAFT TO FINAL

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan DraftRecommendation Statement / Draft Evidence Review Final Recommendation Statement / Evidence Summary